Woodard & Company Asset Management Group’s Gyre Therapeutics GYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q4
Sell
-1
Closed 104
2018
Q3
$0 Hold
1
﹤0.01% 260
2018
Q2
$47 Hold
1
﹤0.01% 215
2018
Q1
$0 Hold
1
﹤0.01% 220
2017
Q4
$0 Buy
+1
New ﹤0.01% 226